{
  "id": 10444829,
  "title": "Novo Nordisk's next-gen weight loss drug outperforms Zepbound in new trial",
  "url": "https://urgent.news/2026/09/28/novo-nordisks-next-gen-weight-loss-drug-outperforms-zepbound-in-new",
  "topic": "world",
  "section": "World",
  "published": "2026-09-28T12:23:31.000Z",
  "source": {
    "name": "The Hill",
    "slug": "the-hill",
    "url": "https://thehill.com/policy/healthcare/6114202-novo-nordisk-cagrisema-zepbound-comparison-trial-weight-loss-drugs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Novo Nordisk says its potential Wegovy successor helped patients lose more weight than Zepbound in a major clinical trial.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}